Two novel SUCLA2 variants cause mitochondrial DNA depletion syndrome, type 5 in two siblings

Front Neurol. 2024 Jul 11:15:1394150. doi: 10.3389/fneur.2024.1394150. eCollection 2024.

Abstract

Mitochondrial DNA depletion syndrome (MDS), characterized by succinate-CoA ligase deficiency and loss of mitochondrial DNA (mtDNA), is caused by specific variants in nuclear genes responsible for mtDNA maintenance. SUCLA2-related mitochondrial DNA depletion syndrome, type 5 (MTDPS-5), presents as a rare, severe early progressive encephalomyopathy. This report investigates a new family exhibiting clinical manifestations of MTDPS-5 and elucidates the genetic basis of this disorder. In two affected siblings, a novel maternally inherited nonsense variant [c.1234C>T (p.Arg412*)] in the SUCLA2 gene and a unique paternally inherited indel variant (g.48569263-48571020del1758insATGA) were identified. Additionally, the siblings exhibited blood mtDNA content lower than 33% compared to age-matched controls. These findings underscore the importance of assessing SUCLA2 variants in patients with severe early progressive encephalomyopathy, even in the absence of methylmalonic aciduria or mtDNA loss, thereby broaden the mutational spectrum of this gene.

Keywords: MTDPS-5; NGS; SUCLA2; mitochondrial DNA; mitochondrial succinate-CoA ligase; rare disease.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Sichuan Province Research Fund for Transfer of Scientific and Technological Achievements (No. 2022JDZH0029, to JY); the Special Fund for Clinical Research and Translational Medicine from Chinese Academy of Medical Sciences (No. 2022-I2M-C&T-B-117, to JY); the Department of Science and Technology of Sichuan Provincial People’s Hospital (2021LY07); the Department of Science and Technology of Sichuan Province (2022NSFSC1585); the National Natural Science Foundation of China (No. 82300342) and Sichuan Province People’s Hospital Youth Talent Fund (No. 2022QN34).